Huntington’s Disease Foundation allocates $2 million to two research teams
The Huntington’s Disease Foundation has awarded $2 million through its 2026 Transformative Research Awards.

Edivro Company News · Original attributed summary. Source announcement: 2026-10-28.
The Huntington’s Disease Foundation has awarded $2 million through its 2026 Transformative Research Awards. Teams led by Rachel Harding at the University of Toronto and Ai Yamamoto at Columbia University will each receive $1 million.
What will the teams study?
Harding’s collaboration is developing small-molecule approaches aimed at huntingtin. Yamamoto’s project investigates increasing Alfy expression to support cellular clearance of harmful protein aggregates. These are distinct research strategies.
Are treatments available from these grants?
The awards fund investigation and development. The announcement reports no approved therapy or clinical outcome from either new grant. Funding a research proposal does not establish that its intended treatment effect will be achieved.
Source: original issuer announcement.
Questions about this story
These answers summarise the article and refer to its original reporting period.
What will the teams study?
Harding’s collaboration is developing small-molecule approaches aimed at huntingtin. Yamamoto’s project investigates increasing Alfy expression to support cellular clearance of harmful protein aggregates. These are distinct research strategies.
Are treatments available from these grants?
The awards fund investigation and development. The announcement reports no approved therapy or clinical outcome from either new grant. Funding a research proposal does not establish that its intended treatment effect will be achieved.
Publisher
Maya Bennett · Edivro editorial pen name

